Subclinical hypothyroidism, lipid metabolism and cardiovascular disease

被引:111
作者
Delitala, Alessandro P. [1 ]
Fanciulli, Giuseppe [2 ]
Maioli, Margherita [3 ,4 ,5 ]
Delitala, Giuseppe [2 ]
机构
[1] Azienda Osped Univ Sassari, Med Clin, Viale San Pietro 8, I-07100 Sassari, Italy
[2] Univ Sassari, Azienda Osped Univ Sassari, Dept Clin & Expt Med, Viale San Pietro 8, I-07100 Sassari, Italy
[3] Univ Sassari, Dept Biomed Sci, Ctr Dev Biol & Reprogramming CEDEBIOR, Viale San Pietro 43-B, I-07100 Sassari, Italy
[4] CNR, Ist Ric Genet & Biomed, Cagliari, Italy
[5] Univ Bologna, Natl Inst Biostruct & Biosyst, Dept Expt Diagnost & Specialty Med, S Orsola Malpighi Hosp, Via Massarenti 9, I-40138 Bologna, Italy
关键词
Subclinical hypothyroidism; Lipid metabolism; Cardiovascular disease; Cardiovascular risk; CORONARY-HEART-DISEASE; THYROID-STIMULATING HORMONE; INTIMA-MEDIA THICKNESS; L-THYROXINE THERAPY; LOW-DENSITY-LIPOPROTEIN; PLACEBO-CONTROLLED TRIAL; SERUM-FREE THYROXINE; DOUBLE-BLIND; RISK-FACTORS; LEVOTHYROXINE REPLACEMENT;
D O I
10.1016/j.ejim.2016.12.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Subclinical hypothyroidism is defined by elevated serum thyrotropin in presence of normal free thyroid hormones. Lipid metabolism is influenced by thyroid hormone and many reports showed that lipids status worsen alongwith TSH level. Subclinical hypothyroidismhas been also linked to other cardiovascular risk factors such as alteration in blood pressure and increased atherosclerosis. Further evidences suggested that mild dysfunction of thyroid gland is associated withmetabolic syndrome and heart failure. Thyrotropin level seems the best predictor of cardiovascular disease, in particular when its levels are above 10 mU/L. However, despite these observations, there is no clear evidence that levothyroxine therapy in subjects with milder form of subclinical hypothyroidism could improve lipid status and the other cardiovascular risk factors. In this review, we address the effect of thyroid hormone and cardiovascular risk, with a focus on lipid metabolism. (C) 2016 European Federation of Internal Medicine. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:17 / 24
页数:8
相关论文
共 103 条
[1]   Evaluation of Selected Atherosclerosis Risk Factors in Women with Subclinical Hypothyroidism Treated with L-Thyroxine [J].
Adamarczuk-Janczyszyn, Maria ;
Zdrojowy-Welna, Aleksandra ;
Rogala, Natalia ;
Zatonska, Katarzyna ;
Bednarek-Tupikowska, Grazyna .
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 25 (03) :457-463
[2]   Effects of 18 months of l-T4 replacement in women with subclinical hypothyroidism [J].
Adrees, M. ;
Gibney, J. ;
El-Saeity, N. ;
Boran, G. .
CLINICAL ENDOCRINOLOGY, 2009, 71 (02) :298-303
[3]   The effect of L-thyroxine substitution on lipid profile, glucose homeostasis, inflammation and coagulation in patients with subclinical hypothyroidism [J].
Anagnostis, P. ;
Efstathiadou, Z. A. ;
Slavakis, A. ;
Selalmatzidou, D. ;
Poulasouchidou, M. ;
Katergari, S. ;
Karathanasi, E. ;
Dogramatzi, F. ;
Kita, M. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2014, 68 (07) :857-863
[4]  
[Anonymous], 1972, JAMA, V220, P996
[5]   Molecular and structural biology of thyroid hormone receptors [J].
Apriletti, JW ;
Ribeiro, RCJ ;
Wagner, RL ;
Feng, W ;
Webb, P ;
Kushner, PJ ;
West, BL ;
Nilsson, S ;
Scanlan, TS ;
Fletterick, RJ ;
Baxter, JD .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1998, 25 :S2-S11
[6]   Effect of L-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein(a) [J].
Arem, R ;
Escalante, DA ;
Arem, N ;
Morrisett, JD ;
Patsch, W .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (12) :1559-1563
[7]   LIPOPROTEIN AND APOLIPOPROTEIN LEVELS IN SUBCLINICAL HYPOTHYROIDISM - EFFECT OF LEVOTHYROXINE THERAPY [J].
AREM, R ;
PATSCH, W .
ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (10) :2097-2100
[8]  
Bilic-Komarica Edina, 2012, Med Arch, V66, P364
[9]   The clinical significance of subclinical thyroid dysfunction [J].
Biondi, Bernadette ;
Cooper, David S. .
ENDOCRINE REVIEWS, 2008, 29 (01) :76-131
[10]   SUBCLINICAL HYPOTHYROIDISM AND HYPERLIPOPROTEINEMIA - INDISCRIMINATE L-THYROXINE TREATMENT NOT JUSTIFIED [J].
BOGNER, U ;
ARNTZ, HR ;
PETERS, H ;
SCHLEUSENER, H .
ACTA ENDOCRINOLOGICA, 1993, 128 (03) :202-206